June 9, 2021
The Rockefeller Foundation has announced over $20 million in funding to help strengthen global capabilities to detect and respond to pandemic threats by strengthening organisations’ ability to sequence and share genomic information alongside other data, rapidly. Oxford Nanopore is one of 20 organisations collaborating with the Rockefeller Foundation to shape their new Pandemic Prevention Institute and expand [...]
June 8, 2021
New Multi Reflecting Time-of-Flight (MRT) mass spectrometry platform from Waters delivers highest quality resolution at fast speedsi. Exceptional clarity of molecular structures and location in tissues for spatial-omics applications with enhanced Desorption Electrospray Ionization (DESI) and new Matrix-Assisted Laser Desorption Ionization (MALDI) imaging sources. Waters SELECT SERIES MRT platform to serve as basis for next [...]
INTEGRA Biosciences takes decisive step in sustainability
June 8, 2021
INTEGRA Biosciences has made significant progress towards its goal of minimizing its ecological footprint with the installation of new photovoltaic systems at the company’s US facilities in Hudson, NH. These systems will provide 77 percent of the total energy requirement for both the company’s US headquarters and production center, saving as much CO2 as 2900 cars or [...]
June 8, 2021
Trace Matters Scientific in collaboration with Thermo Fisher Scientific successfully demonstrated the proof-of-principle for SPionTM Technology for mass spectrometry. For the experiments conducted at Thermo Fisher’s San Jose office, SPionTM Technology was coupled to Thermo Fisher’s TSQ AltisTM Triple Quadrupole Mass Spectrometer, one of the world’s most sensitive mass spectrometers in the market. The experimental results acquired using [...]
June 8, 2021
PHILADELPHIA – Integral Molecular has expanded its partnership with Funakoshi, a leader in distributing life science research reagents and services, to be the exclusive provider of Integral Molecular’s therapeutic antibody characterization technologies in Japan. The partnership will provide researchers with access to antibody characterization technologies optimized to deliver IND-ready results in as little as 4 [...]
June 8, 2021
Centennial, Colo. — Essent Biologics™, a nonprofit biotechnology company setting a new standard in human-derived biomaterials and comprehensive data for research, today announced the launch of its human mesenchymal stem cells (hMSCs) for regenerative medicine, biopharmaceutical and cell therapy research. Essent Biologics will provide highly-characterized, low-passaged hMSCs. Each vial will contain over one million cells [...]
June 8, 2021
SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 Kappa (B.1.617.1) variant strain. The company is also working on controls for the [...]
June 8, 2021
Third Board appointment of 2021 supports long-term vision for the company’s technology platform BOSTON -- 908 Devices (NASDAQ: MASS), a pioneer of purpose-built, handheld and desktop mass spectrometry devices for chemical and biomolecular analysis, has appointed Marcia Eisenberg, Ph.D., chief scientific officer of Labcorp Diagnostics, to serve on its Board of Directors effective immediately. Dr. Eisenberg has extensive experience [...]
TetraScience releases life sciences R&D Data Cloud in AWS Marketplace
June 8, 2021
BOSTON -- TetraScience, a cloud-native and open R&D Data Cloud for scientific discovery, announced today that its flagship product, the Tetra R&D Data Cloud , is now available as a SaaS solution in AWS Marketplace in the Lifesciences category. TetraScience is an AWS Independent Software Vendor (ISV) Partner and the R&D Data Cloud solution is certified as reviewed [...]
BIO-TECHNE JOINS CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY CONSORTIUM
June 8, 2021
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced it is joining the Cell and Gene Therapy Catapult process analytical technology (PAT) consortium, which includes over 20 pharmaceutical companies, technology providers, therapy developers, and charities. The consortium will assess the application and combination of multiple technologies for process analytics within the cell and gene therapy industry. [...]

